DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Erlizumab
Erlizumab
Antibody Formation in Transfusion Therapy
Recommended INN: List 46
The Two Tontti Tudiul Lui Hi Ha Unit
(12) Patent Application Publication (10) Pub. No.: US 2017/0172932 A1 Peyman (43) Pub
Ep 3178848 A1
I Regulations
Integrins As Therapeutic Targets: Successes and Cancers
CUSTOMS TARIFF - SCHEDULE 99 - I
INN Working Document 05.179 Update 2011
A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum
IUPAC Glossary of Terms Used in Immunotoxicology (IUPAC Recommendations 2012)*
PHARMACEUTICAL APPENDIX to the TARIFF SCHEDULE 2 Table 1
Modifying Post-Surgical Wound Healing
International Nonproprietary Names (Inn) for Biological and Biotechnological Substances
(INN) for Biological and Biotechnological Substances
Summaries Ley (Ed.): Adhesion Molecules: Function and Inhibition
(12) United States Patent (10) Patent No.: US 9,446,134 B2 Maggio (45) Date of Patent: *Sep
International Nonproprietary Names (INN) for Biological and Biotechnological Substances
Top View
International Nonproprietary Names for Biological and Biotechnological Substances: a Review17
©Copyright 2012 Nathan Ken Yee
Wo 2010/095940 A2
Integrins As Therapeutic Targets: Successes and Cancers
Pharmaabkommen A1 E
Customs Tariff - Schedule Xxi - 1
Signalling Via Integrins: Implications for Cell Survival and Anticancer Strategies ⁎ Stephanie Hehlgans, Michael Haase, Nils Cordes
Promises and Limitations of Targeting Adhesion Molecules for Therapy
Esophagitis: Drugs Picture of Iron Pill Material in Biopsy TT’S Kodachrome 1St Page Folder Iron Medication Injury Medications/Drugs
A Single Animal Species-Based Prediction of Human Clearance and First-In-Human Dose of Monoclonal Antibodies: Beyond Monkey
Immunomodulatory Treatment for the Intractable Paediatric Epilepsies Luis E
(INN) for Biological and Biotechnological Substances
( 12 ) United States Patent
Thalidomide - Wikipedia, the Free Encyclopedia
Rationale for Immunotherapeutic Combinations in Solid Tumors
Assessment of the Evolution of Cancer Treatment Therapies
WO 2015/036956 Al 19 March 2015 (19.03.2015) P O P C T
L:\0900\0900PHARMAPPX .Wpd
International Nonproprietary Names (INN) for Biological and Biotechnological Substances
Dexamethasone to Reduce Stem Cell Accumulation in the Spleen
(12) 按照专利合作条约所公布的国际申请w O 2016/050208